Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026 and Aug 2026.
- Largest single sale: $4.8M (139,245 shares) of Mineralys Therapeutics, Inc. on Jan 5, 2026. Filing
- Last sale before this period: Oct 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Feb 9, 2023 | Aug 12, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 10, 2026, Mineralys Therapeutics, Inc.: sold 2,170 shares for $59K, under a disclosed plan; 2,170 shares acquired by exercising options. 1 filing: 1
- Jul 17, 2026, Mineralys Therapeutics, Inc.: sold 416 shares for $11K, under a disclosed plan; 416 shares acquired by exercising options. 1 filing: 1
- Jul 15, 2026, Mineralys Therapeutics, Inc.: sold 6,349 shares for $169K, under a disclosed plan. 1 filing: 1
- Jul 13, 2026, Mineralys Therapeutics, Inc.: sold 14,058 shares for $388K, under a disclosed plan; 14,058 shares acquired by exercising options. 1 filing: 1
- Jul 9, 2026, Mineralys Therapeutics, Inc.: sold 2,171 shares for $66K, under a disclosed plan; 2,171 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.